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Lrig1 is a marker of human interfollicular epidermal
stem cells and helps maintain stem cell quiescence.
We show that, in mouse epidermis, Lrig1 defines the
hair follicle junctional zone adjacent to the sebaceous
glands and infundibulum. Lrig1 is a Myc target gene;
loss of Lrig1 increases the proliferative capacity of
stem cells in culture and results in epidermal hyper-
proliferation in vivo. Lrig1-expressing cells can give
rise toall of theadult epidermal lineages in skin recon-
stitution assays. However, during homeostasis and
on retinoic acid stimulation, they are bipotent,
contributing to the sebaceous gland and interfollicu-
lar epidermis. b-catenin activation increases the size
of the junctional zone compartment, and loss of Lrig1
causes a selective increase in b-catenin-induced
ectopic hair follicle formation in the interfollicular
epidermis. Our results suggest that Lrig1-positive
cells constitute a previously unidentified reservoir of
adult mouse interfollicular epidermal stem cells.
INTRODUCTION
Homeostasis in adult tissues requires balanced proliferation and
differentiation. In many cases, this depends on resident stem
cells that self-renew and produce the appropriate differentiated
lineages of the tissue (Morrison and Spradling, 2008). Stem cells
reside in unique microenvironments, niches, that are required to
maintain the cells’ unique properties (Fuchs et al., 2004; Watt
and Hogan, 2000).
Mammalian epidermis comprises the interfollicular epidermis
(IFE) with associated hair follicles (HF), sebaceous glands (SG),
and sweat glands. There are believed to be distinct populations of
stemcells in different locations. The lineages that they feed are nor-
mally constrained by signals from their local environment, but they
can give rise to all epidermal lineages in response to appropriate
stimuli (Chuong, 2007; Jones et al., 2007; Owens and Watt, 2003).
In human IFE, clusters of stem cells have been identified on the
basis of long-term self-renewal ability in culture and quiescencein vivo; these cells express a range of markers, including high
levels of b1 integrins (Gambardella and Barrandon, 2003; Watt,
2002). In contrast, in mouse epidermis, the best characterized
stem cell population is in a region of the HF known as the bulge;
these cells express keratin 15, CD34, and LGR5 and include
asubpopulationof infrequently dividing,DNA label-retainingcells
(LRC) (Cotsarelis et al., 1990; Jaks et al., 2008; Liu et al., 2003;
Trempus et al., 2003). Recent lineage tracing has established
that mouse IFE can be temporarily reconstituted from bulge
stem cells (Ito et al., 2005; Levy et al., 2007) but is maintained
by actively cycling cells that divide or differentiate according to
stochastic principles (Clayton et al., 2007). Thus, the mouse IFE
stem cell compartment has proved elusive.
In a screen for human epidermal stem cell markers, we identi-
fied Leucine-rich repeats and immunoglobulin-like domain
protein 1 (LRIG1) (Jensen andWatt, 2006). LRIG1 is a transmem-
brane protein that interacts with and decreases signaling by
ErbB growth factor receptors (Gur et al., 2004; Jensen and
Watt, 2006; Laederich et al., 2004).
Expression of Lrig1 is required for epidermal homeostasis, as
genetic deletion of Lrig1 leads to epidermal hyperplasia in mouse
skin (Suzuki et al., 2002). Knockdown of Lrig1 in cultured human
keratinocytes causes increased proliferation associated with stem
cell expansion (Jensen and Watt, 2006). In cultured keratinocytes,
LRIG1 negatively regulates EGF-induced ERK MAPK signaling
anddecreases cMyc transcription, RNA, andprotein levels (Jensen
and Watt, 2006). Because epidermal overexpression of Myc can
stimulate both proliferation and terminal differentiation (Arnold
and Watt, 2001; Waikel et al., 2001), it has been proposed that
Myc-induced differentiation acts as a fail-safe device to prevent
uncontrolled proliferation of stem cells (Jensen and Watt, 2006).
We have now examined Lrig1 expression and function in
mouse epidermis. We report that Lrig1 expression defines
a previously uncharacterized multipotent stem cell population,
which normally contributes to the IFE and SG lineages.
RESULTS
Lrig1 Expression Specifies a Unique Population
of Epidermal Cells during Development
At E14.5, prior to HF placode formation, Lrig1 was expressed at
low levels in dorsal epidermis and at higher levels by a
Cell Stem Cell 4, 427–439, May 8, 2009 ª2009 Elsevier Inc. 427
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Lrig1-Positive Epidermal Stem Cellssubpopulation of dermal cells (Figure S1A available online). At
E17.5 and E18.5, Lrig1 expressionwas upregulated in the P-cad-
herin dim population of multipotent stem cells in the developing
HF (Nowak et al., 2008) and was absent from the P-cadherin
bright cells at the base (Figures 1A, S1B, and S1F–S1H). Thus,
during development, the presumptive bulge stem cell population
expressed Lrig1. This expression pattern persisted at P1, except
that from then onward, dermal expression was reduced
(Figure S1C). Q-PCR of RNA isolated from back skin samples
(Figure S1D) revealed that Lrig1 levels peaked at P1.
In whole mounts of tail epidermis (Braun et al., 2003), the
distinct location of the Lrig1-positive population was visualized
readily at P1 and P5. b1 integrin is highly expressed by the devel-
oping hair follicle stem cell population, expression extending
distally from the bulge to the HF bulb (Figures 1B and S1E).
Lrig1-expressing cells in the upper part of the follicle expressed
low levels of b1 integrins. By P5, tail epidermal sebaceous glands
start to develop; they arose from the Lrig1-positive region of the
HF and were themselves Lrig1 positive (Figure S1E, asterisk).
Lrig1 Expression Defines a Distinct Population
of Cells in Adult Epidermis
In adult telogen back and tail epidermis (resting phase of the hair
growth cycle), Lrig1 expression defined a distinct population of
cells at the junction between the infundibulum and the SG
(Figures 1C–1F), but Lrig1 was no longer detectable in the SG
(Figure 1C). Lrig1 is the first reported marker of the junctional
zone between the HF bulge, SG, and infundibulum (Figure 1I).
Figure 1. Lrig1 Expression Defines
a Distinct Population of Epidermal Cells in
the Junctional Zone
(A–H) Immunofluorescence labeling of sections of
embryonic (A) and adult back (C) and tail (D) skin
and whole mounts of embryonic (B) and adult
(E–H) tail epidermis. Adult skin was in telogen
(C–F and H) or early anagen (G). Skin was from
wild-type (A, B, upper panel of C, D, E, G, and H)
or Lrig1-null mice (lower panel of C, F).
Insert in (G) shows the bulb at a higher magnifica-
tion. Color coding indicates antibody labeling.
Dashed lines represent the boundary between
dermis and epidermis (A and C) or demarcate
hair follicles (B and G).
epi, epidermis; de, dermis; IFE, interfollicular
epidermis; SG, sebaceous gland; JZ, junctional
zone; BU, bulge; BB, bulb; HFSC, developing
hair follicle stem cell compartment; PL, hair follicle
placode; HG, hair germ. (A) is shown at a higher
magnification in Figures S1F–S1H. Scale bars,
25 mm (A and D) and 100 mm (B and E–H).
(I) Diagram illustrating the different regions of adult
epidermis. Red, junctional zone; green, bulge.
Whereas Lrig1-positive cells in the
junctional zone were present throughout
the hair growth cycle, two additional sites
of Lrig1 expression were found exclu-
sively in anagen (growing) follicles.
Lrig1-positive cells were detected in the
outer-root sheath below the level of the
SGs (Figure 1G, bar and asterisk), extending toward the bulge.
They were also found in a ring of cells above the bulb (Figure 1G,
asterisk and insert).
Lrig1-expressing cells in adult mouse epidermis were largely
quiescent. In anagen, the zone of Lrig1 expression above the
bulb separated the highly proliferative bulb cells from the rest
of the outer-root sheath (Figure 1G). In the junctional zone of
Lrig1-positive cells, there were fewer Ki67-positive cells than in
the adjacent SGs (Figure 1H). In late anagen, the Lrig1-positive
cells below the level of the SGs included DNA label-retaining
cells, another indicator of quiescence (Braun et al., 2003;
Figure 2A).
We compared Lrig1 expression in telogen epidermis with
expression of markers previously reported to define bulge
stem cells (CD34, Keratin 15, high levels of a6 integrin) (Lyle
et al., 1998; Tani et al., 2000; Trempus et al., 2003). Lrig1-positive
cells expressed high levels of a6 integrin (Figures 1D–1F) but
were negative for CD34 (Figure 2B). They lacked Keratin 15
(Figure 2C) and expressed low levels of Sca1, which is highly
expressed in the infundibulum and IFE (Jensen et al., 2008;
Figure 2D).
Isolation of Lrig1-Expressing Cells
To test the ability of Lrig1-positive cells to self-renew and
contribute to different epidermal lineages, we used flow cytom-
etry to isolate cells expressing Lrig1. The Lrig1 extracellular
domain is sensitive to the trypsinization conditions normally
used to disaggregate epidermal cells; however, the Lrig1 epitope428 Cell Stem Cell 4, 427–439, May 8, 2009 ª2009 Elsevier Inc.
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Lrig1-Positive Epidermal Stem CellsFigure 2. Characterization of Lrig1-Expressing Cells in Adult Epidermis
(A–D) Immunofluorescence labeling of tail epidermal whole mounts fromwild-type mice. Skin was in anagen (A) or telogen (B–D). Color coding indicates antibody
labeling. Scale bars, 100 mm.
(E) Flow cytometry of telogen epidermis from wild-type (WT) and Lrig1-null (KO) epidermis disaggregated with thermolysin and labeled with antibodies to a6
integrin, Lrig1, CD34, and Sca1. Colored gates in top-right panel correspond to populations in lower-right panel and in (F) and (G).
(F) Colony-forming efficiency of wild-type primary keratinocytes isolated as in (E).
(G) Q-PCR of RNA from 105 wild-type epidermal cells isolated as in (E).
(F and G) Data are means ± SEM (n = 4).Cell Stem Cell 4, 427–439, May 8, 2009 ª2009 Elsevier Inc. 429was retained when cells were disaggregated with thermolysin
(Figure 2E and data not shown). When disaggregated epidermal
cells were double-labeled with antibodies to a6 integrin and
Lrig1, the Lrig1-positive population had high a6 levels
(Figure 2E), consistent with the immunolocalization data (Figures
1C–1E). The specificity of Lrig1 labeling was demonstrated by
frozen section and whole-mount immunostaining and flow
cytometry of cells from Lrig1-null mice (Figures 1C, 1F, and2E). As expected (Figures 2B and 2D), Lrig1-positive cells lacked
CD34 and had low levels of Sca1 (Figure 2E).
To examine clonal growth capacity, undifferentiated, a6-
positive basal cells (low forward and side scatter; all) were sorted
into different fractions: a6, CD34 double-positive (CD34+); a6,
Lrig1 double-positive (Lrig1+); and a6-positive, CD34, Lrig1
double-negative (CD34-Lrig1) cells (Figure 2F). Only the
Lrig1-positive population was enriched for clonal growth ability
Cell Stem Cell
Lrig1-Positive Epidermal Stem CellsFigure 3. Epidermal Reconstitution by Lrig1-Expressing Cells
(A–C) Keratinocytes isolated from the back skin of wild-type adult telogen (7-week-old) mice were sorted into a6 integrin-high (I) and -low (II) populations (A).
Populations I (B) and II (C) were gated into three further populations on the basis of Sca1 and CD34 expression, yielding a total of six discrete populations of
keratinocytes (1–3 in [B]; 4–6 in [C]).
(D) RNA from each of the six populations or total live cells (low forward/side scatter; all) were analyzed using Q-PCR for the genes indicated (mean ± SEM, n = 5).
(E–P) Epidermal cells from telogen back skin of GFP-expressingmice were fractionated based on Sca1, a6 integrin, and CD34 expression as in (A)–(C) or Lrig1 (as
in Figure 2E) for epidermal reconstitution experiments by mixing GFP-positive and GFP-negative epidermal cells. Four cell populations were compared: a6 high
(ItgA6H), CD34 positive, Sca1 negative (population 1; enriched for bulge cells; [E], [I], and [M]); a6 high, CD34 negative, Sca1 negative (population 2; enriched for
Lrig1-positive cells; [F], [J], and [N]); a6 high, CD34 negative, SCA1 positive (population 3; [G], [K], and [O]); or Lrig1 positive ([H], [L], [P]). (E–H) Dermal view
of grafts; (I-P) Sections of grafts labeled with GFP antibody (brown) and hematoxylin counterstain (blue). Interfollicular epidermis (IFE), hair follicles (HF), and
sebaceous glands (SG) are indicated. Scale bars, 100 mm (I–L) and 25 mm (M–P).relative to unselected a6-positive cells (Figure 2F). Thus, Lrig1
expression defines a distinct population of highly clonogenic
epidermal cells.
We next analyzed RNA from flow-sorted cells (Figure 2G). As
predicted, Lrig1-expressing cells did not express the bulge
markers CD34 and Lgr5 (Jaks et al., 2008; Trempus et al.,
2003). They also lacked hair keratin 6a, a marker of cells in the
bulge and outer-root sheath (Gu and Coulombe, 2007). Lrig1-
positive cells expressed low levels of Sca1 and the IFE-terminal
differentiation marker keratin 10. Lrig1-positive cells were en-
riched for expression of the putative SG stem cell marker Blimp1
(Horsley et al., 2006; Lo Celso et al., 2008) and had higher cMyc
expression than did CD34+ cells. Thus, Lrig1-expressing cells430 Cell Stem Cell 4, 427–439, May 8, 2009 ª2009 Elsevier Inc.are transcriptionally distinct from bulge stem cells and
committed HF and IFE cells.
To allow isolation of junctional zone cells from trypsinized and
Lrig1-null epidermis, we developed a second sorting strategy.
Undifferentiated (low forward and side scatter) epidermal kerati-
nocytes were sorted into six distinct populations based on
CD34, a6 integrin, and Sca1 expression (Jensen et al., 2008;
Figures 3A–3C). Epidermal cells were divided into a6 integrin-
high (I in Figure 3A) or -low (II in Figure 3A) populations (Blanpain
et al., 2004; Jensen et al., 2008; Silva-Vargas et al., 2005). These
two populations were each fractionated into three further
groups—CD34 positive, Sca1 negative (1 in Figure 3B; 4 in
Figure 3C); CD34 negative, Sca1 negative (2 in Figure 3B; 5 in
Cell Stem Cell
Lrig1-Positive Epidermal Stem CellsFigure 3C); or CD34 negative, Sca1 positive (3 in Figure 3B; 6 in
Figure 3C)—and RNA was isolated from all six populations. The
color coding of the different populations in Figures 3B and 3C
matches the colors in Figure 3D. Cells in population 2 were, as
expected, enriched for Lrig1 expression (Figures 3A–3D and
Figures S2A–S2F) and had the same RNA expression profile as
cells sorted with Lrig1 antibodies (Figures S2D–S2F; cf.
Figure 2G). We conclude that sorting CD34-negative, Sca1-
negative, a6 integrin-high cells represents an alternative strategy
for enriching Lrig1-positive cells.
Lrig1-Expressing Cells Can Contribute to All
Epidermal Lineages
To examine the capacity of Lrig1-positive cells to generate
different epidermal lineages, we isolated cells on the basis of
CD34, Sca1, and a6 integrin expression from mice expressing
GFP under the control of the chicken b-actin promoter. The 105
sortedGFP-positive cellswere combinedwith 33 106 unlabeled,
unfractionated epidermal cells from a wild-type (GFP-negative)
mouse. The low ratio of GFP-positive to GFP-negative cells al-
lowed subsequent clonal analysis. The disaggregated epidermal
cells were combined with P2 dermal cells, injected into a silicone
chamber on the back of a nude mouse, and allowed to reconsti-
tute skin for 4–5weeks.Wecompared bulge cells (CD34 positive,
Sca1 negative, a6 high) (population 1 in Figure 3B) with Lrig1-
enriched cells (CD34 negative, Sca1 negative, a6 high) (popula-
tion 2 in Figure 3B) and CD34-negative, Sca1-positive, a6-high
cells (population 3 in Figure 3B), which have previously been
reported to be lineage-committed IFE cells (Jensen et al.,
2008). We also isolated Lrig1, GFP double-positive cells from
thermolysin-treated epidermis using Lrig1 antibodies and
combined themwith unfractionated, trypsin-disaggregated cells.
At 4–5 weeks postgrafting, grafts were analyzed for the contri-
bution of GFP-positive cells to SGs, HFs, and IFE. When viewed
macroscopically from the dermal side, the contribution of all four
populations of GFP-positive cells to HFs was evident (Figures
3E–3H). Theextent of contributionof eachpopulationwassimilar:
6% ± 4% of HFs contained GFP-positive, Lrig1-enriched cells,
compared to 1% ± 1% for CD34-positive cells and 3% ± 1%
forSca1-positive cells (n = 3±SEM). The number of reconstituted
follicles was lower following thermolysin treatment, reflecting
decreased cell viability (Figure 3H and data not shown).
By staining sections with GFP antibodies, we established that
all four populations founded IFE clones of varying size and
contributed to HFs and SGs (Figures 3I–3P). All HFs and SGs
that contained GFP-positive cells also had a contribution of
GFP-negative cells (Figures 3I–3L and 3P). None of the sorted
populations were restricted in terms of contribution to the
different HF lineages (Figures 3I–3L and 3P).
We conclude that populations of bulge stem cells, Lrig1-
positive cells, and the Sca1-positive cells previously reported
to be committed IFE cells (Figure 2D) all contain multipotent cells
that contribute to all lineages in reconstituted epidermis.
Lrig1 Expression Controls Proliferation
in the Interfollicular Epidermis
We next generated Lrig1-null mice by breeding heterozygous
animals and compared null, heterozygous, and wild-type
littermates. We saw no differences between wild-type andheterozygous animals. The tail epidermis of Lrig1-null mice was
thicker than that of wild-type (Figures 4A and 4B), and HFs
protruded at a greater angle (Figures 4C and 4D). There was no
SG hyperplasia, and the hair growth cycle was not grossly per-
turbed (Figures 4A and 4B and data not shown). Expression of
Keratin 10 and Keratin 15 was normal (Figures 4E and 4I and
datanot shown). As reportedpreviously,Keratin 6wasexpressed
in Lrig1-null IFE, consistent with epidermal hyperproliferation
(Suzuki et al., 2002; data not shown). Flow cytometry for Sca1,
CD34, and a6 integrin (Figures 4F and 4J and data not shown)
demonstrated that loss of Lrig1 did not affect the size of any of
the six cell populations defined in Figures 3A–3C. Thus, loss of
Lrig1 did not change the size of the bulge stem cell compartment
or the population of cells that normally express Lrig1.
The most striking phenotype was an increase in IFE prolifera-
tion. In embryonic and P1 epidermis, the effect was evident in
some areas (Figures 4G and 4K), but the mean data from repli-
cate samples was not statistically significant (Figure 4M).
However, in adult skin, there was a marked increase both in
Ki67-positive cells and in BrdU-labeled S phase cells (Figures
4H, 4L, 4M, and data not shown).
Consistentwith increased epidermal proliferation, the numberof
DNA label-retainingcells inadultLrig1-null epidermiswassubstan-
tially reduced (Figures 4N and 4O). This was quantitated by flow
cytometric analysis of label-retaining cells in the bulge (CD34 posi-
tive, Sca1 negative, a6 high), the cells that would normally express
Lrig1 (CD34negative, Sca1negative,a6high), and total undifferen-
tiatedepidermalcells (a6positive) (Figure4P). Thenumber of label-
retaining cells was decreased in all three populations.
These results demonstrate that Lrig1 is required for stem cell
quiescence in adult mouse epidermis, as observed in cultured
human epidermis (Jensen and Watt, 2006).
Lrig1 and cMyc Form an Autoregulatory Feedback Loop
Activation of Myc in the basal layer of mouse epidermis results in
increased proliferation (Arnold and Watt, 2001; Waikel et al.,
2001), whereas, in cultured human epidermal keratinocytes,
LRIG1 overexpression decreases Myc levels and reduces prolif-
eration (Jensen and Watt, 2006). There was upregulation of Myc
protein and mRNA in the tail skin of Lrig1-null mice (Figure 5A).
This suggests that the increased proliferation of Lrig1-null
epidermis is attributable, at least inpart, to increasedMycactivity.
To examine whether Myc activation affected Lrig1 expression,
we examined the epidermis of K14MycER-transgenic mice
following topical application of 4-hydroxy-Tamoxifen (4OHT)
(Arnold and Watt, 2001). Myc activation resulted in increased
Lrig1 mRNA levels in telogen back skin (Figure 5B). There was
an increase in Lrig1-expressing cells in the junctional zone,
with Lrig1-positive cells extending upwards into the adjacent
IFE (Figures 5D–5G).
Examination of 1.6 kb upstream of the Lrig1 transcriptional
start site revealed several E boxes, including a pair at 1546
and 1391 bp (Figure 5H). When the upstream sequence was
coupled to luciferase and transiently transfected into K14MycER
keratinocytes, we observed a 4OHT concentration-dependent
induction of Lrig1 promoter activity when compared to normal
cells (Figure 5C).
Following chromatin immunoprecipitation (ChIP) of cells from
4OHT-treated K14MycER back skin, one region of the Lrig1Cell Stem Cell 4, 427–439, May 8, 2009 ª2009 Elsevier Inc. 431
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(A and B) Hematoxylin and eosin-stained sections of adult tail skin.
(C and D) Macroscopic view of adult tails.
(E, I, G, H, K, L, N, and O) Tail whole mounts of P1 (G and K) and adult telogen (E, I, N, and O) and anagen (H and L) epidermis. WT, wild-type; KO, Lrig1 null. Color
coding indicates antibody labeling.
(F and J) Flow cytometry of (F) WT and (J) KO Sca1-low cells with antibodies to CD34 and a6 integrin. The percentage of cells in each quadrant is indicated.
(M) Quantitation of Ki67-positive cells in KO IFE expressed relative to WT controls. Data shows mean ± SEM; average of three fields per whole mount and five
mice per sample.
(N–P) BrdU label-retaining cells were examined following a 70 day chase period.
(P) Cells were subjected to flow cytometry with antibodies to Sca1, CD34, and a6 integrin. The percentage of cells in each group that were BrdU labeled is shown.
Error bars represent SD (WT n = 8; KO n = 6). WT, wild-type; KO, Lrig1 null.
Scale bars, 100 mm (A, B, G, H, K, M, and O) and 200 mm (E and I).promoter containing the two E boxes was specifically enriched in
two independent biological replicates (Figure 5I). As a positive
control, we confirmed that the promoter of Nucleolin, a known432 Cell Stem Cell 4, 427–439, May 8, 2009 ª2009 Elsevier Inc.Myc target gene, was also enriched in cMyc binding (Figure 5I).
A genomic sequence 7 kb downstreamof theNucleolin promoter
was not bound (Figure 5I, Ctrl). In addition, knockdown of Myc
Cell Stem Cell
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(A) (Top) Immunoblot of protein lysates from tail skin of adult littermates lacking (KO) or heterozygous (Het) for Lrig1. Each lane contains protein from a separate
mouse. Blot was probed for Myc or, as a loading control, b-tubulin (Tub). (Bottom) Q-PCR for cMyc from adult littermates lacking (KO) or heterozygous (Het) for
Lrig1. Expression levels are relative to Gapdh, and error bars represent SD (n = 3).
(B) Q-PCR for Lrig1mRNA in back skin of WT and K14MycER-transgenic mice treated with 4OHT for 8 days. Expression levels are relative to Gapdh, and error
bars represent SD (n = 3).
(C) Luciferase assay using 1.6 kb of the Lrig1 promoter in murine keratinocytes fromWT or K14MycERmice, represented as induction in K14MycER cells relative
to WT cells. Cells were treated with the 4OHT concentrations indicated (nM). Error bars represent SD (n = 4).
(D–G) Back skin sections (D and E) and tail epidermal whole mounts (F and G) of wild-type (WT) and K14MycERmice treated with 4OHT for the number of days
shown. Color coding indicates antibody labeling. Scale bars, 100 mm.
(H) Location of two E boxes in the Lrig1 promoter.
(I) Quantitative ChIP from keratinocytes isolated from back skin of WT or K14MycER-transgenic mice treated with 4OHT for 4 days.
(J) Knockdown of cMyc in primary cultures of WT keratinocytes causes a decrease in Lrig1 transcript levels. Error bars represent SD (n = 4).Cell Stem Cell 4, 427–439, May 8, 2009 ª2009 Elsevier Inc. 433expression in primary mouse keratinocytes using RNAi led to
a comparable reduction in Lrig1 expression (Figure 5J).
We conclude that cMyc positively regulates Lrig1 and that the
two proteins are involved in a feedback loop that controls their
expression (Jensen and Watt, 2006).
Lineage Analysis of Junctional Zone Cells
The phenotype of Lrig1-null epidermis (Figure 4) suggested that,
although Lrig1-positive cells could contribute to all of theepidermal lineages in skin reconstitution assays (Figure 3), their
role in epidermal homeostasis might be to maintain the IFE. To
investigate this, we exploited the low stochastic leakiness asso-
ciated with Keratin 14 promoter-driven CreER recombination
events (Hong et al., 2004; Vasioukhin et al., 1999). K14CreER
mice were crossed with CAG-CAT-eGFP (stop-flox-GFP) mice
(Kawamoto et al., 2000), in which Cre-mediated recombination
results in GFP expression in the descendents of each cell in
which the recombination event occurred (Bleul et al., 2006;
Cell Stem Cell
Lrig1-Positive Epidermal Stem CellsFigure 6. Lineage Analysis of Junctional Zone Cells
(A) Schematic summary of the twomouse lines that were crossed for lineage tracing. Leakiness of Cre expression in the absence of 4OHTwas exploited for clonal
analysis.
(B and C) Sections of back skin stained for GFP, showing two examples of junctional zone clones. (B0) Insert in (B) shown at higher magnification.
(D) Schematic diagram showing contribution of junctional zone clones (green) to IFE and SG in control (left) and ATRA-treated skin.
(E) Cumulative frequency plots of the size distribution of GFP-positive clones originating in the IFE, junctional zone, infundibulum, SG, and HF (below the level of
the SG). Clone size (volume) was determined from 3D reconstructions of confocal images. Diagrams represent ranking based on cumulative percentage of clones
as a function of clone size (exponential scale) in control (blue) and ATRA-treated (red) skin.
(F and G) Three-dimensional projections of whole-mount reconstructions stained for GFP and LRIG1. Color coding indicates antibody labeling. GFP expression is
shown by isosurface labeling. (F) Control. (G) Treated with ATRA.
(H) Clone size distribution in control (ctrl) and ATRA-treated skin. Data from (E) are replotted as box and whisker plot of GFP clone sizes (volume) in the different
epidermal regions in control and ATRA-treated tail epidermis. Minimum and maximum clone sizes are marked by whiskers; upper and lower box boundaries
indicate clones in the 25th to 75th percentile, and cross (+) indicates median clone size. Asterisk indicates statistically significant change in median clone
size following ATRA treatment (p < 0.05, two-tailed unpaired Mann-Whitney test). Scale bars, 100 mm (B, C, F, and G) and 25 mm (B0).Figure 6A). Recombination mainly occurs postnatally, and from
3months, epidermal GFP-positive clones are readily detectable.
It has previously been reported that, under steady-state condi-
tions, the IFE is primarily maintained by committed progenitors
located within the IFE; however, any contribution of cells in the
junctional zone or infundibulum was excluded from the analysis
(Clayton et al., 2007). In back skin from4-month-oldK14CreER3
stop-flox-GFP animals, clones of GFP-expressing cells were de-
tected in all epidermal regions: junctional zone, infundibulum,434 Cell Stem Cell 4, 427–439, May 8, 2009 ª2009 Elsevier Inc.IFE, SG, and HF. The clones of GFP cells in the junctional zone
(Figure 6B) occasionally extended into the infundibulum and IFE
(Figure 6C). To examine the response of the junctional zone pop-
ulation to increased IFE proliferation, we treated K14CreER 3
stop-flox-GFP mice with all-trans retinoic acid (ATRA) for
4 days, which preferentially stimulates IFE proliferation (Collins
and Watt, 2008; data not shown).
Three-dimensional reconstructions of epidermal wholemounts
were analyzed with Volocity software. The size (volume) of
Cell Stem Cell
Lrig1-Positive Epidermal Stem Cellsindividual GFP clones located in the junctional zone (n = 85 in
control [ctrl] epidermis; n = 161 in ATRA-treated epidermis), IFE
(n = 1184 ctrl, 1525 ATRA), infundibulum (n = 81 ctrl, 152 ATRA),
SG (n=53ctrl, 80ATRA), andHF (n=65ctrl, 293ATRA)wasdeter-
mined, and the cumulative frequency distribution of clone sizes
was plotted (Figure 6E). In control epidermis, the median clone
size (50% ranking in Figure 6E; ‘‘+’’ in Figure 6H) was similar in
IFE,HF, junctional zone,and infundibulumbut significantlysmaller
in the SG (p < 0.05, two-tailed unpaired Mann-Whitney test).
The only category of clone to enlarge significantly upon ATRA
treatment was that originating in the junctional zone (Figures 6D
and 6H; p < 0.05; Mann-Whitney two-tailed unpaired test). The
increase was observed for all clone sizes falling between the
25th and 100th percentile (25%–100% ranking in Figure 6E).
ATRA treatment also resulted in the enlargement of junctional
zone clones compared with ATRA-treated clones in the IFE,
infundibulum, SG, and HF (Figure 6H; p < 0.05). Both before
and after ATRA treatment, junctional zone clones contributed
cells to the infundibulum, IFE, and SG, but not to the HF below
the SG (Figures 6F and 6G). Conversely, HF clones never
contributed to the junctional zone.
These results indicate that, although Lrig1-positive cells give
rise to HF lineages in skin reconstitution assays (Figure 3), they
are bipotent in intact skin (Figure 6D). In response to an IFE prolif-
erative stimulus, there is selective expansion of junctional zone
clones into the IFE and SG (Figure 6D).
Loss of Lrig1 Results in Expansion of the Junctional
Zone Stem Cell Compartment and Increased
b-Catenin Responsiveness
To examine the effects of Lrig1 loss on keratinocyte growth in
culture, we performed clonal growth assays on the six epidermal
populations sorted on the basis of CD34, Sca1, and a6 expres-
sion from the back skin of telogenmice (Figure 7A). There was an
increase in the colony-forming efficiency of each population and
also of total basal cells (all: a6 positive, low forward, and side
scatter). This is consistent with expression of Lrig1 in all subpop-
ulations of cells, albeit at different levels (Figure S2E), and with
upregulation of cMyc in cultured keratinocytes (Figure 5 and
data not shown). However, the increase was most dramatic in
the CD34-negative, Sca1-negative, a6 integrin-high population,
the cells that normally are highly enriched for Lrig1 expression.
We conclude that, in the absence of Lrig1, this population of cells
has a selective growth advantage.
The expansion of clonal growth on loss of Lrig1 is reminiscent
of the effects of activating b-catenin (Silva-Vargas et al., 2005).
Therefore, we examined Lrig1 expression in K14DNb-cat-
eninER-transgenic mice, in which b-catenin is activated by
4OHT treatment (Lo Celso et al., 2004; Silva-Vargas et al.,
2005). b-catenin activation resulted in an increase in Lrig1-
positive cells in the junctional zone and adjacent IFE (Figures
7B and 7C), as observed in K14MycER mice (Figures 5F and
5G). Lrig1 was also expressed in ectopic follicles (Figures 7C,
arrow and insert). There was a 2-fold increase in the a6
integrin-high, Lrig1-positive population (Figures 7D and 7E)
and a 4-fold increase in the CD34-negative, Sca1-negative,
a6-high population (population 2 in Figures S2G and S2H).
Q-PCR analysis showed an increase in Lrig1 mRNA in
response to b-catenin (Figure 7F). However, 5 kb upstream ofthe Lrig1 transcription start site did not contain TCF- and
Lef-binding sites, and Lrig1 expression was unaffected when
b-catenin signaling was blocked with an N terminally truncated
Lef1 transgene (data not shown). Lrig1 expression was not
induced in keratinocytes by Wnt3A under conditions in which
known target genes, Axin2 and Jagged1 (Estrach et al., 2006;
Lustig et al., 2002), were induced (Figure 7G). In contrast,
cMyc, a known target of b-catenin (He et al., 1998) was upregu-
lated upon activation of b-catenin (Figure 7F). Moreover, upon b-
catenin activation, there was a substantial increase in the
amount of endogenous Myc associated with the E boxes on
the Lrig1 promoter (Figure 7H). We conclude that, upon b-cate-
nin activation, the Lrig1-positive compartment expands, but this
reflects upregulation of cMyc because Lrig1 expression is not
directly regulated by b-catenin.
To examine the consequences of loss of Lrig1 on b-catenin
activation, we crossed K14DNb-cateninER mice with Lrig1-null
mice and examined adult tail epidermis following 4OHT treat-
ment. On a wild-type background, 4OHT treatment induces
ectopic HFs in the IFE, SGs, and existing follicles (Silva-Vargas
et al., 2005). Activation of b-catenin in the absence of Lrig1
caused expansion of the junctional zone and a selective increase
in ectopic follicles in the IFE, particularly in the vicinity of the junc-
tional zone (Figures 7I and 7J). Lrig1 loss led to someSG enlarge-
ment on b-catenin activation, but there was no increase in the
number of ectopic follicles arising from the SG or existing follicles
(Figures 7I, 7J, 7L, and 7M).
In addition to quantitating the ectopic follicles per unit length of
IFE (Figure 7K), we scored epithelial cell clusters expressing
CDP, an early marker of ectopic follicle formation (Silva-Vargas
et al., 2005) (Figure 7N). There was an increase in CDP-positive
clusters, irrespective of cluster size (Figure 7N). Thus, Lrig1
loss affects ectopic follicle number rather than size.
We conclude that activation of b-catenin in the absence of
Lrig1 causes an increase in the number of junctional zone stem
cells and that they can form ectopic HF.
DISCUSSION
Wehave defined a distinct population ofmultipotent stem cells in
the junctional zone of the HF that expresses Lrig1. In epidermal
reconstitution experiments, these cells contribute as effectively
as bulge stem cells to all of the epidermal lineages. However,
lineage analysis suggests that they are bipotent in steady-state
epidermis, giving rise to cells in the IFE and SG.
It has been reported that, during normal epidermal homeo-
stasis, the IFE can be maintained by committed progenitors
(Clayton et al., 2007). Following wounding, bulge stem cells
contribute only transiently to the IFE (Ito et al., 2005), whereas
cells originating above the bulge stem cell compartment or in
the infundibulum contribute long-term (Levy et al., 2007). Several
lines of evidence suggest that the junctional zone constitutes this
previously unidentified reservoir of IFE stem cells. Lineage
tracing demonstrates that cells in the junctional zone contribute
to the infundibulum, SG, and, occasionally, the IFE. In response
to ATRA, which causes IFE proliferation, there is selective expan-
sion of junctional zone clones into these compartments. More-
over, activation of b-catenin causes a marked increase in the
size of the junctional zone compartment. In Lrig1-null epidermis,Cell Stem Cell 4, 427–439, May 8, 2009 ª2009 Elsevier Inc. 435
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Lrig1-Positive Epidermal Stem CellsFigure 7. Effect of Lrig1 Loss on Stem Cell Renewal and Responsiveness to b-Catenin Activation
(A) Clonal growth assays of primary keratinocytes sorted based on CD34, Sca1, and a6 integrin (Figure 3A–C) from the skin of wild-type (WT) and Lrig1-null (KO)
adult littermates. Error bars represent SD (n = 3). Six-hundred Sca1-negative cells and 2500 Sca1-positive and unfractionated cells were seeded; representative
dishes are shown.436 Cell Stem Cell 4, 427–439, May 8, 2009 ª2009 Elsevier Inc.
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number of ectopic HFs that form specifically in the IFE adjacent
to the infundibulum, but not elsewhere. This cannot simply be
due to increased IFE proliferation in Lrig1-null epidermis
because ATRA treatment, which stimulates IFE proliferation,
does not affect b-catenin-induced ectopic HF formation (Collins
and Watt, 2008; C.A.C. and F.M.W., unpublished data).
The Lrig1-positive population is specified early in develop-
ment, coinciding with the formation of the HF stem cell niche
(Nowak et al., 2008), and persists during adulthood. Lrig1-
expressing stem cells can be isolated directly via Lrig1 or en-
riched on the basis of high a6 integrin expression and lack of
CD34 and Sca1. Cells that express Lrig1 are negative for the
bulge markers keratin 6a, keratin 15, CD34, and Lgr5 (Liu
et al., 2003; Trempus et al., 2003; Jaks et al., 2008). They show
elevated expression of Blimp1, a previously reported marker of
SG stem cells (Horsley et al., 2006), and of the Lgr family member
Lgr6 (Hsu et al., 2000). Expression of MTS24/Plet1, which is
reported to be a marker of Sca1-negative, CD34-negative kera-
tinocytes (Jensen et al., 2008; Nijhof et al., 2006), was not specif-
ically upregulated in Lrig1-expressing cells. Lrig1 is the first
marker of the junctional zone to be described, and cells in this
region have a unique gene expression profile.
Lrig1 was originally identified as a human IFE stem cell marker
that keeps cells in a quiescent, nondividing state (Jensen and
Watt, 2006). Consistent with those observations, loss of Lrig1
in mouse epidermis resulted in hyperproliferation in the IFE.
Lrig1 loss did not affect the HFs or SGs. In contrast, loss of the
transcriptional repressor Blimp1 selectively induces excessive
proliferation in the SG (Horsley et al., 2006), whereas loss of
NFATc1 causes continuous HF cycling (Horsley et al., 2008).
Loss of Lrig1, Blimp1, or NFATc1 is characterized by reduction
in the number of LRCs as they are recruited into the cell cycle.
Thus, it appears that these three proteins function in concert to
maintain quiescence in different epidermal stem cell compart-
ments.
We found that Lrig1 and Myc participate in an autoregulatory
feedback loop; cMyc regulates transcription of the Lrig1 gene,
and Lrig1 negatively regulates Myc expression (Figure 6; Jensen
and Watt, 2006). It has also been shown that Blimp1 is a direct
negative regulator of Myc (Horsley et al., 2006). This may explain
why ectopic activation of Myc under the control of the keratin 14
promoter causes hyperplasia of both IFE and SG (Arnold and
Watt, 2001;Waikel et al., 2001), whereas loss of Lrig1 specificallyaffects the IFE. It is interesting that Myc is required for anagen
entry (Soucek et al., 2008) because this coincides with the
appearance of the ring of Lrig1-positive cells above the HF
bulb (Figure 1G).
In epidermal reconstitution experiments, Lrig1-enriched cells
and Lrig1-positive cells were as effective as bulge cells in
contributing to the different epidermal lineages. Surprisingly,
Sca1-positive cells, previously reported to be committed
progenitors of the IFE (Jensen et al., 2008), were also capable
of contributing to HFs and SGs. We suggest that the behavior
of cells in different regions of the epidermis is normally con-
strained by signals from their local environment (Owens and
Watt, 2003). However, most, if not all, epidermal cells that are
competent to proliferate will exhibit multilineage differentiation
potential when challenged genetically (Silva-Vargas et al.,
2005), by wounding (Ito et al., 2007), or in epidermal reconstitu-
tion experiments. This would certainly be consistent with recent
observations on the properties of cells from different regions of
the ocular surface (Majo et al., 2008). Important questions for
the future arewhether all of the different epidermal stem cell pop-
ulations arise from the P-cadherin-low, Lrig1-positive cells in
developing HFs and whether the different stem cell populations
in adult epidermis have a hierarchical relationship or are
completely autonomous.
EXPERIMENTAL PROCEDURES
Mice and Labeling Experiments
Lrig1-null (Suzuki et al., 2002), K14MycER (Arnold and Watt, 2001), K14DN-
b-cateninER (line D2) (Lo Celso et al., 2004), K14CreER (Hong et al., 2004;
kind gift from B. Stripp), CAG-CAT-eGFP (Kawamoto et al., 2000; kind gift
from J. Miyazaki), and b-actin-eGFP (C57BL/6 jax strain, stock number:
003291) mice have been described previously. In some experiments, mice
were treated with 4-hydroxy-Tamoxifen (4OHT) at a concentration of
1.5 mg/200 ml in acetone three times a week on the back and tail. Some
mice were treated with 100 ml 0.5mM ATRA (Sigma) in acetone on back and
tail as described (Collins and Watt, 2008). DNA label-retaining cells were
generated by repeated BrdU injections of neonatal mice, as described previ-
ously (Braun et al., 2003).
Flow Cytometry
Keratinocytes were isolated from telogen dorsal back skin using either trypsin
as described (Silva-Vargas et al., 2005) or thermolysin (Walzer et al., 1989). To
isolate epidermal cells using thermolysin, we rinsed back skin in 10%Betadine
and 70% ethanol and washed it in PBS. The dermal side was thoroughly
scraped to remove excess fat, and then the tissue was floated in 0.25 mg/ml(B and C) Tail epidermal whole mounts of WT and K14DNb-cateninERmice treated with 4OHT for 3 weeks. Arrow and insert indicate Lrig1-positive ectopic folli-
cles in interfollicular epidermis.
(D and E) Flow cytometric analysis for Lrig1 and a6 integrin of cells fromWT andK14DNb-cateninERmice treatedwith 4OHT for 3 weeks. The proportion of cells in
each fraction is indicated.
(F) Q-PCR of Lrig1 and cMycmRNA in back skin of WT and K14DNb-cateninER-transgenic mice treated with 4OHT for 2 weeks. Expression levels are relative to
Gapdh, and error bars represent SD (n = 3).
(G) Q-PCR of levels of Lrig1, Axin2, and Jagged1 in primarymurine epidermal keratinocytes treated withWnt3A. Data are expressed relative to unstimulated cells.
Error bars represent SD (n = 3).
(H) ChIP analysis of endogenous cMyc on the Lrig1 promoter in WT and K14DNb-cateninER mice treated with 4OHT for 10 days. Data represent two separate
samples and show level of isolated genomic DNA relative to amount of input DNA.
(I–M) Hematoxylin and eosin stained sections (I and J) and whole mounts (L and M) of adult tail epidermis from K14DNb-cateninER3 Lrig1 heterozygous (het) or
knockout (KO)mice treated with 4OHT for 3 weeks. The number of ectopic HFs formed from the interfollicular epidermis was scored bymorphology (K) and by the
appearance of clusters of CDP-expressing cells (N) (two independent experiments; KO, n = 8;WT, n = 7). Arrows in (J) indicate expanded infundibulum with asso-
ciated ectopic follicles.
In (B), (C), (L), and (M), color coding indicates antibody labeling. Scale bars, 100 mm (B and C) and 200 mm (I, J, L, and M).Cell Stem Cell 4, 427–439, May 8, 2009 ª2009 Elsevier Inc. 437
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Lrig1-Positive Epidermal Stem CellsThermolysin (Sigma) in calcium-free FAD medium for 1 hr at 37C. The
epidermis was subsequently scraped from the dermis, minced with scalpels,
and disaggregated by gentle pipetting. Thermolysin was inactivated by addi-
tion of FCS, and the cells were pelleted and resuspended for labeling with anti-
bodies (see Supplemental Data). Cell sorting was carried out using a MoFlo
high-speed sorter (Dako Cytomation), and analysis was carried out on
a CyAN ADP analyzer (Dako Cytomation). All data analysis was conducted
using the FlowJo program.
Hair Reconstitution Assays
The experiments were performed essentially as described previously (Jensen
et al., 2008). Each graft consisted of 105 GFP-expressing epidermal cells
mixed with 3 3 106 unlabeled, unsorted epidermal cells and 5 3 106 dermal
cells isolated from neonatal fibroblasts. We typically isolated 105 cells per
mouse of Lrig1-positive cells or the two groups of a6 integrin-high, Sca1-nega-
tive cells. The tops of the graft chambers were removed 1 week after grafting,
and the chambers were removed 1 week later. Hair growth was typically
observed 1 week after chamber removal. Mice were sacrificed and analyzed
4–5 weeks postgrafting.
Mouse Keratinocyte Culture
Mouse keratinocytes were isolated and cultured on a J2 3T3 feeder layer as
described (Silva-Vargaset al., 2005). For clonalgrowthassays,600 to2500cells
wereplatedperwell in 6-well platesandcultured for 2weeksprior to fixationand
staining with 1% Rhodamine B.
Statistical Analysis
The significance of quantitative data was tested using the unpaired, two-tailed
Student’s t test. Data from the lineage analysis experiments were analyzed
using an unpaired, two-tailed Mann-Whitney test.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures and
two figures and can be found with this article online at http://www.cell.com/
cell-stem-cell/supplemental/S1934-5909(09)00168-4.
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